What we do

NextEra uses publicly available information about pathogens and novel computational modeling and simulations to optimize vaccine formulations and regiments. 

NextEra can produce cGMP level vaccine formulations using recombinant human protein or mRNA-LNP technologies and perform preclinical testing.